These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 10526671

  • 1. Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy.
    Potters L, Cha C, Oshinsky G, Venkatraman E, Zelefsky M, Leibel S.
    Cancer J Sci Am; 1999; 5(5):301-6. PubMed ID: 10526671
    [Abstract] [Full Text] [Related]

  • 2. Isotope selection for patients undergoing prostate brachytherapy.
    Cha CM, Potters L, Ashley R, Freeman K, Wang XH, Waldbaum R, Leibel S.
    Int J Radiat Oncol Biol Phys; 1999 Sep 01; 45(2):391-5. PubMed ID: 10487561
    [Abstract] [Full Text] [Related]

  • 3. Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Adamovich E.
    Urology; 2004 Oct 01; 64(4):754-9. PubMed ID: 15491715
    [Abstract] [Full Text] [Related]

  • 4. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Allen Z, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):32-43. PubMed ID: 15629591
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience.
    Henry AM, Al-Qaisieh B, Gould K, Bownes P, Smith J, Carey B, Bottomley D, Ash D.
    Int J Radiat Oncol Biol Phys; 2010 Jan 01; 76(1):50-6. PubMed ID: 20005453
    [Abstract] [Full Text] [Related]

  • 11. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T, Saito S, Toya K, Yorozu A, Dokiya T, Murai M.
    Int J Urol; 2006 Mar 01; 13(3):218-23. PubMed ID: 16643612
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1056-62. PubMed ID: 15001245
    [Abstract] [Full Text] [Related]

  • 17. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Cancer J; 2001 Mar 15; 7(5):404-12. PubMed ID: 11693899
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy.
    Fang LC, Dattoli M, Taira A, True L, Sorace R, Wallner K.
    Urology; 2008 Jan 15; 71(1):146-50. PubMed ID: 18242384
    [Abstract] [Full Text] [Related]

  • 20. Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.
    Fitch DL, McGrath S, Martinez AA, Vicini FA, Kestin LL.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1430-9. PubMed ID: 16765527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.